TickerFactsScreenerDevelopers

Editas Medicine, Inc. (EDIT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$5.44M2016: -$50.25M2017: -$9.42M2018: -$45.71M2019: -$40.67M2020: -$179.84M2021: -$163.80M2022: -$177.35M2023: -$132.18M2024: -$210.28M2025: -$165.24M-$165.24M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$165.24M+21.4%
2024-$210.28M-59.1%
2023-$132.18M+25.5%
2022-$177.35M-8.3%
2021-$163.80M+8.9%
2020-$179.84M-342.2%
2019-$40.67M+11.0%
2018-$45.71M-385.4%
2017-$9.42M+81.3%
2016-$50.25M-823.1%
2015-$5.44M—